A PwC report predicts the M&A deal totals could range from $225 billion to $275 billion.
Experts in the field believe that the biotech industry is poised for recovery in 2024, and one reason for that would be a favorable climate for M&A activity. A PwC report predicts the M&A deal totals could range from $225 billion to $275 billion. M&A will be among the trends that will influence the biotech market in 2024.